Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (963564)	9/12/2016 6:31:53 PM
From: TopCat	2 Recommendations Recommended By FJB locogringo Read Replies (1) \| Respond to of 1575353

And you are clearly not qualified to quote something from the cdc website.....

To: J_F_Shepard who wrote (963564)	9/12/2016 7:50:44 PM
From: Bonefish	Read Replies (2) \| Respond to of 1575353

There are two. I know an older gentleman who had both shots and still got pneumonia. His strain wasn't covered. There are two different types of pneumococcal vaccine. One that protects adults against 23 strains of Streptococcus pneumonia bacteria is called pneumococcal polysaccharide vaccine (PPSV23), and it is marketed under the brand name Pneumovax. PPSV23 is made using dead bacteria. The dead germs cannot make you sick. The other is pneumococcal conjugate vaccine, PCV13 (brand name Prevnar 13), which is routinely given to infants and toddlers, but was approved by the FDA in 2011 for use in adults ages 50 and older. It protects against up to 13 strains of pneumococcal bacteria.